Cargando…

Simultaneous Determination of Five Cytochrome P450 Probe Substrates and Their Metabolites and Organic Anion Transporting Polypeptide Probe Substrate in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry

A rapid and selective liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the simultaneous determination of organic anion transporting polypeptide 1B1 (OATP1B1) and cytochrome P450 (P450) probe substrates and their phase I metabolites in human plasma was developed. The OATP1B1 (pita...

Descripción completa

Detalles Bibliográficos
Autores principales: Heo, Jae-Kyung, Kim, Hyun-Ji, Lee, Ga-Hyun, Ohk, Boram, Lee, Sangkyu, Song, Kyung-Sik, Song, Im Sook, Liu, Kwang-Hyeon, Yoon, Young-Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160928/
https://www.ncbi.nlm.nih.gov/pubmed/30004443
http://dx.doi.org/10.3390/pharmaceutics10030079
_version_ 1783358875954577408
author Heo, Jae-Kyung
Kim, Hyun-Ji
Lee, Ga-Hyun
Ohk, Boram
Lee, Sangkyu
Song, Kyung-Sik
Song, Im Sook
Liu, Kwang-Hyeon
Yoon, Young-Ran
author_facet Heo, Jae-Kyung
Kim, Hyun-Ji
Lee, Ga-Hyun
Ohk, Boram
Lee, Sangkyu
Song, Kyung-Sik
Song, Im Sook
Liu, Kwang-Hyeon
Yoon, Young-Ran
author_sort Heo, Jae-Kyung
collection PubMed
description A rapid and selective liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the simultaneous determination of organic anion transporting polypeptide 1B1 (OATP1B1) and cytochrome P450 (P450) probe substrates and their phase I metabolites in human plasma was developed. The OATP1B1 (pitavastatin) and five P450 probe substrates, caffeine (CYP1A2), losartan (CYP2C9), omeprazole (CYP2C19), dextromethorphan (CYP2D6), and midazolam (CYP3A) and their metabolites were extracted from human plasma (50 µL) using methanol. Analytes were separated on a C18 column followed by selected reaction monitoring detection using MS/MS. All analytes were separated simultaneously within a 9 min run time. The developed method was fully validated over the expected clinical concentration range for all analytes tested. The intra- and inter-day precisions for all analytes were lower than 11.3% and 8.82%, respectively, and accuracy was 88.5–117.3% and 96.1–109.2%, respectively. The lower limit of quantitation was 0.05 ng/mL for dextromethorphan, dextrorphan, midazolam, and 1′-hydroxymidazolam; 0.5 ng/mL for losartan, EXP-3174, omeprazole, 5′-hydroxyomeprazole, and pitavastatin; and 5 ng/mL for caffeine and paraxanthine. The method was successfully used in a pharmacokinetic study in healthy subjects after oral doses of five P450 and OATP1B1 probes. This analytical method provides a simple, sensitive, and accurate tool for the determination of OATP1B1 and five major P450 activities in vivo drug interaction studies.
format Online
Article
Text
id pubmed-6160928
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61609282018-10-01 Simultaneous Determination of Five Cytochrome P450 Probe Substrates and Their Metabolites and Organic Anion Transporting Polypeptide Probe Substrate in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry Heo, Jae-Kyung Kim, Hyun-Ji Lee, Ga-Hyun Ohk, Boram Lee, Sangkyu Song, Kyung-Sik Song, Im Sook Liu, Kwang-Hyeon Yoon, Young-Ran Pharmaceutics Article A rapid and selective liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the simultaneous determination of organic anion transporting polypeptide 1B1 (OATP1B1) and cytochrome P450 (P450) probe substrates and their phase I metabolites in human plasma was developed. The OATP1B1 (pitavastatin) and five P450 probe substrates, caffeine (CYP1A2), losartan (CYP2C9), omeprazole (CYP2C19), dextromethorphan (CYP2D6), and midazolam (CYP3A) and their metabolites were extracted from human plasma (50 µL) using methanol. Analytes were separated on a C18 column followed by selected reaction monitoring detection using MS/MS. All analytes were separated simultaneously within a 9 min run time. The developed method was fully validated over the expected clinical concentration range for all analytes tested. The intra- and inter-day precisions for all analytes were lower than 11.3% and 8.82%, respectively, and accuracy was 88.5–117.3% and 96.1–109.2%, respectively. The lower limit of quantitation was 0.05 ng/mL for dextromethorphan, dextrorphan, midazolam, and 1′-hydroxymidazolam; 0.5 ng/mL for losartan, EXP-3174, omeprazole, 5′-hydroxyomeprazole, and pitavastatin; and 5 ng/mL for caffeine and paraxanthine. The method was successfully used in a pharmacokinetic study in healthy subjects after oral doses of five P450 and OATP1B1 probes. This analytical method provides a simple, sensitive, and accurate tool for the determination of OATP1B1 and five major P450 activities in vivo drug interaction studies. MDPI 2018-07-02 /pmc/articles/PMC6160928/ /pubmed/30004443 http://dx.doi.org/10.3390/pharmaceutics10030079 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Heo, Jae-Kyung
Kim, Hyun-Ji
Lee, Ga-Hyun
Ohk, Boram
Lee, Sangkyu
Song, Kyung-Sik
Song, Im Sook
Liu, Kwang-Hyeon
Yoon, Young-Ran
Simultaneous Determination of Five Cytochrome P450 Probe Substrates and Their Metabolites and Organic Anion Transporting Polypeptide Probe Substrate in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry
title Simultaneous Determination of Five Cytochrome P450 Probe Substrates and Their Metabolites and Organic Anion Transporting Polypeptide Probe Substrate in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry
title_full Simultaneous Determination of Five Cytochrome P450 Probe Substrates and Their Metabolites and Organic Anion Transporting Polypeptide Probe Substrate in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry
title_fullStr Simultaneous Determination of Five Cytochrome P450 Probe Substrates and Their Metabolites and Organic Anion Transporting Polypeptide Probe Substrate in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry
title_full_unstemmed Simultaneous Determination of Five Cytochrome P450 Probe Substrates and Their Metabolites and Organic Anion Transporting Polypeptide Probe Substrate in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry
title_short Simultaneous Determination of Five Cytochrome P450 Probe Substrates and Their Metabolites and Organic Anion Transporting Polypeptide Probe Substrate in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry
title_sort simultaneous determination of five cytochrome p450 probe substrates and their metabolites and organic anion transporting polypeptide probe substrate in human plasma using liquid chromatography-tandem mass spectrometry
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160928/
https://www.ncbi.nlm.nih.gov/pubmed/30004443
http://dx.doi.org/10.3390/pharmaceutics10030079
work_keys_str_mv AT heojaekyung simultaneousdeterminationoffivecytochromep450probesubstratesandtheirmetabolitesandorganicaniontransportingpolypeptideprobesubstrateinhumanplasmausingliquidchromatographytandemmassspectrometry
AT kimhyunji simultaneousdeterminationoffivecytochromep450probesubstratesandtheirmetabolitesandorganicaniontransportingpolypeptideprobesubstrateinhumanplasmausingliquidchromatographytandemmassspectrometry
AT leegahyun simultaneousdeterminationoffivecytochromep450probesubstratesandtheirmetabolitesandorganicaniontransportingpolypeptideprobesubstrateinhumanplasmausingliquidchromatographytandemmassspectrometry
AT ohkboram simultaneousdeterminationoffivecytochromep450probesubstratesandtheirmetabolitesandorganicaniontransportingpolypeptideprobesubstrateinhumanplasmausingliquidchromatographytandemmassspectrometry
AT leesangkyu simultaneousdeterminationoffivecytochromep450probesubstratesandtheirmetabolitesandorganicaniontransportingpolypeptideprobesubstrateinhumanplasmausingliquidchromatographytandemmassspectrometry
AT songkyungsik simultaneousdeterminationoffivecytochromep450probesubstratesandtheirmetabolitesandorganicaniontransportingpolypeptideprobesubstrateinhumanplasmausingliquidchromatographytandemmassspectrometry
AT songimsook simultaneousdeterminationoffivecytochromep450probesubstratesandtheirmetabolitesandorganicaniontransportingpolypeptideprobesubstrateinhumanplasmausingliquidchromatographytandemmassspectrometry
AT liukwanghyeon simultaneousdeterminationoffivecytochromep450probesubstratesandtheirmetabolitesandorganicaniontransportingpolypeptideprobesubstrateinhumanplasmausingliquidchromatographytandemmassspectrometry
AT yoonyoungran simultaneousdeterminationoffivecytochromep450probesubstratesandtheirmetabolitesandorganicaniontransportingpolypeptideprobesubstrateinhumanplasmausingliquidchromatographytandemmassspectrometry